SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1840[Some hedging from Adam F.] I get the sense that Medarex is getting a bit frustIcebrg-9/29/2007
1839It seems that no one is expecting success in the melanoma study. That consoles A.J. Mullen-9/28/2007
1838Meanwhile, Medarex shares fell as Zhang [BMO Capital Markets] issued an "UnIcebrg-9/28/2007
1837IBD and C. Difficile Make Deadly Combination By Michael Smith, Senior Staff WriIcebrg-9/27/2007
1836BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE September 25, 2007 Biotie has staIcebrg-9/27/2007
1835>>PharmAthene Awarded Up to $13.9 Million NIH Contract to Develop Anthrax tuck-9/26/2007
1834>>I wonder what Yang knows, that we don't?<< And vice versa. :nigel bates-9/26/2007
1833Analyst Eun Yang, also of Jefferies, initiated coverage of Medarex Inc., a bioteIcebrg-9/26/2007
1832Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of DermaIcebrg-9/25/2007
1831Oxford Genome Sciences Announces New Therapeutic Antibody Deal With Medarex SeLJM-9/18/2007
1830Genmab pleased to be sole owner of drug for glioblastoma - 14/09/2007 A busy daIcebrg-9/17/2007
1829You think that was humorous... The first reply I received from MEDX was a just LJM-9/15/2007
1828With transparency like that, who needs shareholders?rkrw-9/14/2007
1827I sent an email to MEDX for more details re: the multiple oncology disease progrLJM-9/14/2007
1826If she keeps up the good work, will he get palimony from her? :-)rkrw-9/13/2007
1825Could be. After all, DD has had time to counsel Genmab recently.keokalani'nui-9/13/2007
1824That medx is going to get back the rights to drugs, such as the anti-cd20 genmabrkrw-9/13/2007
1823That they >really< think '010 is going to work, and they're lookinnigel bates-9/13/2007
1822No PR from Medarex on the deal. Wonder what exactly this means for medx? <&rkrw-9/13/2007
1821September 13, 09:31 AM Genmab sees further HuMax-Inflam clinical studies after nigel bates-9/13/2007
1820I own a little and if x010 fails and the stock tanks I will own a lot.keokalani'nui-9/11/2007
1819My personal opinion is that mdx-010 is real. A major market fear is that the FDkenhott-9/11/2007
1818I've been outspoken, since landing at S.I., about trials that are designed tscaram(o)uche-9/10/2007
1817<i>There's a 23% short interest in Medarex right now, so I know I'tom pope-9/10/2007
1816Medarex Misses the Mark By Adam Feuerstein Senior Writer 9/10/2007 10:21 AM EDT Icebrg-9/10/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News